Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study

Clinical and Experimental Nephrology

Volumn 19, Issue 3, 2015, Pages 379-386

  Muso, Eri ^a   Mune, Masatoshi ^b   Hirano, Tsutomu ^c   Hattori, Motoshi ^d   Kimura, Kenjiro ^e   Watanabe, Tsuyoshi ^f   Yokoyama, Hitoshi ^g   Sato, Hiroshi ^h   Uchida, Shunya ⁱ   Wada, Takashi ^j   Shoji, Tetsuo ^k   Yuzawa, Yukio ^l   Takemura, Tsukasa ^m   Sugiyama, Satoshi ⁿ   Nishizawa, Yoshiki ^k   Ogahara, Satoru ^o   Yorioka, Noriaki ^p   Sakai, Soichi ^q   Ogura, Yosuke ^q   Yukawa, Susumu ^s   Iino, Yasuhiko ^t   Imai, Enyu ^r   Matsuo, Seiichi ^u   Saito, Takao ^o   more..

^a Kitano Hospital   (Japan)

^b Takaishi Fujii Hospital   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g KANAZAWA MEDICAL UNIVERSITY   (Japan)

^h TOHOKU UNIVERSITY   (Japan)

ⁱ TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^k OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Departments of Nephrology   (Japan)

^o FUKUOKA UNIVERSITY   (Japan)

^p HIROSHIMA UNIVERSITY   (Japan)

^q Kidney Foundation   (Japan)

^r Nakayamadera Imai Clinic   (Japan)

^s Wakayama KD Clinic   (Japan)

^t NIPPON MEDICAL SCHOOL   (Japan)

^u NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Drug resistant nephrotic syndrome; LDL apheresis; Lipid nephrotoxicity; Short term results

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYCLOSPORIN A; DIURETIC AGENT; FIBRINOGEN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; STEROID; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DIURETIC THERAPY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERLIPIDEMIA; HYPOPROTEINEMIA; LOW DENSITY LIPOPROTEIN APHERESIS; MALE; MULTICENTER STUDY; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; STEROID THERAPY; THERAPY EFFECT; CLINICAL TRIAL; COMPLICATION; DRUG RESISTANCE; HYPERLIPIDEMIAS; METABOLISM; MIDDLE AGED; TIME FACTOR; URINE;

ADULT; AGED; BLOOD COMPONENT REMOVAL; DRUG RESISTANCE; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOPROTEINEMIA; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; PROTEINURIA; SERUM ALBUMIN; TIME FACTORS;

EID: 84931007441     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-0996-8     Document Type: Article

References (21)

1. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2:1309–11.
2. Buemi M, Nostro L, Crasci E, Barilla A, Cosentini V, Aloisi C, Sofi T, Campo S, Frisina N. Statins in nephrotic syndrome: a new weapon against tissue injury. Med Res Rev. 2005;25:587–609.
3. Ito S, Machida H, Inaba A, Harada T, Okuyama K, Nakamura T, Aihara Y, Yokota S. Amelioration of steroids and cyclosporine-resistant nephrotic syndrome by pravastatin. Pediatr Nephrol. 2007;22:603–6.
4. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis. 1985;5:613–22.
5. Tojo K, Sakai S, Miyahara T. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Jpn J Nephrol. 1988;30:1153–60.
6. Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis. 2003;42:1121–30.
7. Yokoyama K, Sakai S, Sigematsu T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy. Clin Nephrol. 1998;50:1–7.
8. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant. 1994;9:257–64.
9. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Miki S, Kuwahara T, Takamitsu Y, Takemura T, Tsubakihara Y. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group. Kidney Int Suppl. 1999;71:S122–5.
10. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y. Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron. 2001;89:408–15.
11. Muso E, Mune M, Yorioka N, Nishizawa Y, Hirano T, Hattori M, Sugiyama S, Watanabe T, Kimura K, Yokoyama H, Sato H, Saito T. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS). Clin Nephrol. 2007;67:341–4.
12. Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka M, Asano Y, Kusano E. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol. 2006;65:423–6.
13. Sato Y, Tsunoda S, Nozue T, Pan Q, Wakasugi H, Yoshimura A. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Intern Med. 2012;51:2597–602.
14. Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis. 1993;22:72–82.
15. Diamond JR, Pesek I, McCarter MD, Karnovsky MJ. Altered functional characteristics of rat macrophages during nephrosis. Synergistic effects of hypercholesterolemia. Am J Pathol. 1989;135:711–8.
16. Knisel W, Di Nicuolo A, Pfohl M, Muller H, Risler T, Eggstein M, Seifried E. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med. 1993;234:479–87.
17. Tasaki H, Tsuda Y, Yamashita K, Toyokawa T, Yashiro A, Osajima A, Nakashima Y, Kuroiwa A. Removal of plasma fibrinogen by LDL apheresis. Jpn J Apheresis. 1997;16:263.
18. Petrichenko I, Daret D, Larrue J, Shakhov Y. Effect of VLDL on the inhibition of arachidonic acid transformation by dexamethasone in cultured smooth muscle cells. Biochim Biophys Acta. 1993;1166:183–7.
19. Leon C, Jia J, Qiu G, Hill JS, Wasan KM. Modification in low-density lipoprotein receptor expression affects cyclosporin A cellular uptake and cytotoxicity. J Pharm Sci. 2008;97:2350–61.
20. Ingulli E, Tejani A. Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol. 1992;3:254–9.
21. Stenvinkel P, Alvestrand A, Angelin B, Eriksson M. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion. Eur J Clin Invest. 2000;30:866–70.